Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Couto, SCF"'
Autor:
Ovider, IC, Silva, VJ, Castro, LF, Oliveira, TGM, Almeida, RR, Couto, SCF, Rocha, VG, Ramos, RN
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S988-S988
Autor:
Silva, VJ, Ovider, IC, Azevedo, A, Filgueira, IS, Martinez, GA, Seguro, FS, Cabral-Marques, O, Couto, SCF, Oliveira, TGM, Almeida, RR, Barbuto, JAM, Rocha, VG, Ramos, RN
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S547-S547
Publikováno v:
Annals of Hematology & Oncology. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08adc26c9a3f021362e79c5c9d84e5db
https://doi.org/10.26420/annhematoloncol.2019.1270
https://doi.org/10.26420/annhematoloncol.2019.1270
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S317-S317
Autor:
Lemos, IAP, Silva, VJ, Oliveira, TGM, Couto, SCF, Martinez, GA, Seguro, FS, Barbuto, JAM, Marques, OC, Rocha, V, Ramos, RN
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S312-S312
Autor:
Lima, MPO, Couto, SCF, Ribeiro, PDAC, Silva, VJ, Lemos, IAP, Ros, FA, Oliveira, TGM, Ramos, RN, Junior, AM, Rocha, V
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S295-S295
Autor:
Silva, VJ, Lemos, IAP, Couto, SCF, Oliveira, TGM, Martinez, GA, Seguro, FS, Marques, OC, Barbuto, JAM, Rocha, V, Ramos, RN
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S250-S250
Autor:
Ferreira, AM, Couto, SCF, Oliveira, TGM, Ramos, RN, Mariano, LCB, Hamerschlak, N, Lima, M, Rocha, V
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S271-S271
Autor:
Rós FA; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Postgraduate program in Medical Science, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil. Electronic address: felipe.ros@usp.br., Couto SCF; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Fundação Pró-Sangue-Hemocentro de Sao Paulo, São Paulo, Brazil., Milhomens J; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Ovider I; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Postgraduate program in Medical Science, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Maio KT; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Hospital Israelita Albert Einstein, São Paulo, Brazil., Jennifer V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Postgraduate program in Medical Science, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil., Ramos RN; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Instituto D'Or de Ensino e Pesquisa, São Paulo, Brazil., Picanço-Castro V; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Kashima S; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Calado RT; Center for Cell-Based Therapy, Regional Blood Center of Ribeirão Preto, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil., Barros LRC; Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Fundação Pró-Sangue-Hemocentro de Sao Paulo, São Paulo, Brazil; Center for Translational Research in Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil; Churchill Hospital, Department of Hematology, Churchill Hospital, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Cytotherapy [Cytotherapy] 2023 Dec; Vol. 25 (12), pp. 1300-1306. Date of Electronic Publication: 2023 Jun 15.
Autor:
Couto SCF; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Kowes A; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Aurabi CS; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Oliveira TGM; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil., Klinger P; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology and Cell Therapy, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil.; Fundação Pró-Sangue-Hemocentro de São Paulo, São Paulo, Brazil.; Instituto D'Or de Ensino e Pesquisa, São Paulo, Brazil.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1195759. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).